Unknown

Dataset Information

0

Activating Leptin Receptors in the Central Nervous System Using Intranasal Leptin. A Novel Therapeutic Target for Sleep-disordered Breathing.

ABSTRACT:

SUBMITTER: Ip MSM 

PROVIDER: S-EPMC6423110 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Will Intranasal Leptin Mitigate Opioid-induced Sleep-disordered Breathing?
| S-EPMC7528931 | biostudies-literature
Unknown Intranasal Leptin Prevents Opioid-induced Sleep-disordered Breathing in Obese Mice.
| S-EPMC7528928 | biostudies-literature
Unknown Sleep-disordered breathing and cardiovascular disease.
| S-EPMC4824338 | biostudies-other
Unknown Sleep disordered breathing in bronchopulmonary dysplasia.
| S-EPMC5693767 | biostudies-literature
Unknown Intracerebral hemorrhage and sleep-disordered breathing.
| S-EPMC6082385 | biostudies-literature
Unknown Sleep-disordered breathing and poststroke outcomes.
| S-EPMC7549189 | biostudies-literature
Unknown Sleep-disordered breathing in cystic fibrosis.
| S-EPMC7541673 | biostudies-literature
Unknown Mirtazapine reduces susceptibility to hypocapnic central sleep apnea in males with sleep-disordered breathing: a pilot study.
| S-EPMC8325612 | biostudies-literature
Unknown Current diagnostic trends in sleep disordered breathing.
| S-EPMC3199806 | biostudies-other
Unknown Acute cardiopulmonary failure from sleep-disordered breathing.
| S-EPMC3296458 | biostudies-other